Open Access 10.11.2016 | Original Article
Clinical efficacy and safety of topiroxostat in Japanese hyperuricemic patients with or without gout: a randomized, double-blinded, controlled phase 2b study
Erschienen in: Clinical Rheumatology | Ausgabe 3/2017